Ind-Swift Ltd.
Snapshot View

View in App

Prices View details >>

9.25 -0.20 ▼-2.1%

29 September 2022, 02:22:37 PM
Volume: 23,321

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indswift.com
Market Cap 49.99 Cr.
Enterprise Value(EV) 1,070.44 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -5.89 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 30.82 Trailing Twelve Months Ending 2022-06
Book Value / Share -135.84 Trailing Twelve Months Ending 2022-06
Price to Book Value -0.07 Calculated using Price: 9.23
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 5.42 Cr. 54,164,653 Shares
FaceValue 2
Company Profile
Ind-Swift Limited was incorporated as a public limited company on June 6, 1986 under the Companies Act 1956.It is the flagship company of India based Ind Swift Group. Ind-Swift Limited is a north India based pharmaceutical company.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.12%
1 Week
+2.78%
1 Month
-3.14%
3 Month
-13.95%
6 Month
-19.91%
1 Year
-2.63%
2 Year
+156.94%
5 Year
+34.06%
10 Year
-48.18%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -112.51
Return on Capital Employed (%) -4.27 -10.41 -20.35 -56.22 -10.31 3.37 5.82 7.19 11.69
Return on Assets (%) -8.26 -11.09 -17.47 -42.12 -8.45 1.35 -3.19 -4.68 -3.07

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 217 108 -40 -239 -611 -679 -677 -713 -695 -720
Non Curr. Liab. 609 596 549 679 672 694 659 661 661 634
Curr. Liab. 581 686 718 621 608 598 616 654 706 718
Minority Int.
Equity & Liab. 1,407 1,390 1,228 1,061 669 613 598 602 672 632
Non Curr. Assets 519 506 469 439 463 427 405 373 406 389
Curr. Assets 843 851 738 612 206 186 194 229 265 242
Misc. Exp. not W/O 45 33 21 10
Total Assets 1,407 1,390 1,228 1,061 669 613 598 602 672 632

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 570 417 304 263 270 289 330 356 398 402
Other Income 13 2 13 14 15 8 22 15 24 17
Total Income 583 419 317 277 284 297 352 371 421 419
Total Expenditure -604 -487 -461 -328 -264 -278 -306 -315 -352 -362
PBIDT -21 -68 -144 -52 21 19 46 57 69 57
Interest -77 -40 -19 -16 -11 -4 -35 -52 -57 -58
Depreciation -26 -39 -36 -36 -35 -34 -34 -33 -32 -31
Taxation 9 2 0 -1 -1 -2 0 0
Exceptional Items -260 -28 27 6 -1 1 1
PAT -116 -145 -200 -364 -54 8 -19 -30 -20 -32
Adjusted EPS -23 -29 -40 -67 -10 2 -4 -6 -4 -6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -146 103 86 -106 7 1 43 35 83 90
Cash Fr. Inv. -28 -14 -6 -4 -4 -3 -14 -11 -17 -18
Cash Fr. Finan. 146 -89 -81 110 -11 -4 -13 -26 -54 -84
Net Change -28 0 -1 0 -8 -5 16 -3 12 -13
Cash & Cash Eqvt 18 18 17 17 9 4 20 17 29 16

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 55.55 55.55 55.55 55.55 55.55 55.55 55.55 55.58 55.58
Public 44.45 44.45 44.45 44.45 44.45 44.45 44.45 44.42 44.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 73.46 73.46 73.46 73.46 73.46 73.46 73.46 73.43 42.81

Announcements View Details >>

Fri, 23 Sep 2022
Annual General Meeting
Ind-Swift Limited has informed the Exchange about Proceedings of Annual General Meeting held on 21-Sep-2022
Fri, 23 Sep 2022
Annual General Meeting
Ind-Swift Limited has informed the Exchange about Proceedings of Annual General Meeting held on 21-Sep-2022
Fri, 23 Sep 2022
Change in designation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the shareholder in their 36th Annual General Meeting held on 21st September, 2022 have approved appointment of Sh. Bhupinder Singh as an Independent Director of the Company for term of five consecutive years, w.e.f 23rd June, 2022.

Technical Scans View Details >>

Wed, 28 Sep 2022
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 3 Months High Decrease 3 Months
High Increase 2 Years High Increase 2 Years
Closing Near 20 SMA Closing Near 20 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,222.96 931.85 +1.5%
Divi's Laboratories Ltd. 98,114.53 3,714.95 +0.3%
Cipla Ltd. 88,495.80 1,118.60 +2.0%
Dr. Reddy's Laboratories Ltd. 71,034.40 4,379.85 +2.6%
Apollo Hospitals Enterprise Ltd. 61,344.29 4,382.60 +2.7%
Torrent Pharmaceuticals Ltd. 50,536.67 1,537.95 +2.9%
Alkem Laboratories Ltd. 39,477.37 3,213.40 -2.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.55 931.85 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.60 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-06 35.56 1,118.60 +2.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.75 4,379.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.44 4,382.60 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.09 1,537.95 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-06 30.25 3,213.40 -2.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 931.85 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.89 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-06 4.12 1,118.60 +2.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.51 4,379.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.32 4,382.60 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 7.91 1,537.95 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-06 4.50 3,213.40 -2.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 931.85 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 1,118.60 +2.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,379.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,382.60 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.95 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 0.30 3,213.40 -2.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 931.85 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,118.60 +2.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,379.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,382.60 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.95 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,213.40 -2.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 931.85 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,118.60 +2.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,379.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,382.60 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.95 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,213.40 -2.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 931.85 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,118.60 +2.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,379.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,382.60 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.95 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 10,634.19 3,213.40 -2.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 931.85 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,118.60 +2.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,379.85 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,382.60 +2.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.95 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 1,680.32 3,213.40 -2.5%

FAQ's On Ind-Swift Ltd.

What is Ind-Swift share price?
Can I buy Ind-Swift shares now?
What is the Market Cap of Ind-Swift?
What is the 52 Week High and Low of Ind-Swift?
What is the trend of Ind-Swift share price?